A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours

Clinical trial NCT01578239 · COMPLETED

Trial details

NCT number: NCT01578239
Sponsor: Advanced Accelerator Applications
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoid Tumor of the Small Bowel Neuroendocrine Tumour

Start date: 2012-09-06
Primary completion: 2015-07-31
Enrollment: 231

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.